艾滋病毒感染、急性冠状动脉综合征、经皮冠状动脉介入治疗与高血小板反应性：引发完美血栓风暴的因素。 - Suppr | 超能文献

HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm.

作者信息

Gurbel Paul A, deFilippi Christopher R, Bliden Kevin P, Tantry Udaya S

机构信息

Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA, USA.

出版信息

Eur Heart J. 2017 Jun 1;38(21):1687-1689. doi: 10.1093/eurheartj/ehw630.

DOI:10.1093/eurheartj/ehw630

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm.艾滋病毒感染、急性冠状动脉综合征、经皮冠状动脉介入治疗与高血小板反应性：引发完美血栓风暴的因素。

Eur Heart J. 2017 Jun 1;38(21):1687-1689. doi: 10.1093/eurheartj/ehw630.

2

[Impact of novel P2Y12 receptor inhibitors on platelet reactivity in acute coronary syndrome patients undergoing percutaneous coronary intervention].新型P2Y12受体抑制剂对接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者血小板反应性的影响

Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Feb;44(2):138-43. doi: 10.3760/cma.j.issn.0253-3758.2016.02.011.

3

A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.一项关于接受经皮冠状动脉介入治疗（PCI）的急性冠状动脉综合征（ACS）患者血小板功能引导下抗血小板治疗降阶梯的随机试验。急性冠状动脉综合征慢性抗血小板治疗中血小板抑制反应性测试（TROPICAL-ACS）试验的原理与设计。

Thromb Haemost. 2017 Jan 5;117(1):188-195. doi: 10.1160/TH16-07-0557. Epub 2016 Sep 22.

4

Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study.急性冠状动脉综合征双联抗血小板治疗的人类免疫缺陷病毒感染患者的血小板反应性：EVERE2ST-HIV 研究。

Eur Heart J. 2017 Jun 1;38(21):1676-1686. doi: 10.1093/eurheartj/ehw583.

5

Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.通过VerifyNow P2Y12检测评估的P2Y12反应单位与血小板抑制百分比的组合，是接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者长期临床结局的有用预测指标。

Thromb Res. 2016 Mar;139:114-20. doi: 10.1016/j.thromres.2016.01.020. Epub 2016 Jan 27.

6

Changes in platelet function independent of pharmacotherapy following coronary intervention in non-ST-elevation myocardial infarction patients.非ST段抬高型心肌梗死患者冠状动脉介入治疗后血小板功能的变化（与药物治疗无关）

Atherosclerosis. 2015 Nov;243(1):320-7. doi: 10.1016/j.atherosclerosis.2015.09.024. Epub 2015 Sep 21.

7

The relationship between on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes in Chinese patients.中国患者中氯吡格雷治疗时的血小板反应性、基因型与经皮冠状动脉介入治疗术后结局的关系。

Scand J Clin Lab Invest. 2015 May;75(3):223-9. doi: 10.3109/00365513.2014.993696. Epub 2015 Jan 16.

8

Potent effect of prasugrel on acute phase resolution of intra-stent athero-thrombotic burden after percutaneous intervention to acute coronary syndrome.普拉格雷对经皮冠状动脉介入治疗急性冠状动脉综合征后支架内动脉粥样血栓性负担急性期消退的强效作用。

J Cardiol. 2018 Nov;72(5):403-410. doi: 10.1016/j.jjcc.2018.04.004. Epub 2018 May 4.

9

Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.急性冠状动脉综合征经皮冠状动脉介入治疗患者负荷剂量替格瑞洛后用 VASP 检测血小板反应性。

Thromb Res. 2013 Jul;132(1):e15-8. doi: 10.1016/j.thromres.2013.04.030. Epub 2013 May 30.

10

CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.CHADS2 和 CHA2DS2-VASc 评分作为急性冠状动脉综合征血小板反应性的预测因子。

J Cardiol. 2021 Apr;77(4):375-379. doi: 10.1016/j.jjcc.2020.09.010. Epub 2020 Oct 13.

引用本文的文献

1

Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent.阿司匹林作为COVID-19的辅助药物治疗选择：一种药物兼具抗炎、抗血栓形成和抗病毒作用。

J Exp Pharmacol. 2021 Dec 7;13:957-970. doi: 10.2147/JEP.S330776. eCollection 2021.

2

Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites.强化抗逆转录病毒疗法对氯吡格雷和普拉格雷活性代谢物药代动力学和疗效的影响。

Clin Pharmacokinet. 2018 Oct;57(10):1347-1354. doi: 10.1007/s40262-018-0637-6.